Dalfampridine Patent Expiration
Dalfampridine is Used for improving walking in patients with multiple sclerosis. It was first introduced by Merz Pharmaceuticals Llc A Sub Of Merz Therapeutics Gmbh
Dalfampridine Patents
Given below is the list of patents protecting Dalfampridine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ampyra | US8007826 | Sustained release aminopyridine composition | May 26, 2027 | Merz Pharms |
| Ampyra | US8354437 | Method of using sustained release aminopyridine compositions | Dec 22, 2026 | Merz Pharms |
| Ampyra | US8440703 | Methods of using sustained release aminopyridine compositions | Apr 08, 2025 | Merz Pharms |
| Ampyra | US8663685 | Sustained release aminopyridine composition | Jan 18, 2025 | Merz Pharms |
| Ampyra | US9918973 | Sustained release aminopyridine composition |
Dec 13, 2024
(Expired) | Merz Pharms |
| Ampyra | US5540938 | Formulations and their use in the treatment of neurological diseases |
Jul 30, 2018
(Expired) | Merz Pharms |
Dalfampridine's Family Patents
Explore Our Curated Drug Screens
Dalfampridine Generic API Manufacturers
Several generic applications have been filed for Dalfampridine. The first generic version for Dalfampridine was by Actavis Laboratories Fl Inc and was approved on Jan 23, 2017. And the latest generic version is by Rising Pharma Holding Inc and was approved on Jul 6, 2020.
Given below is the list of companies who have filed for Dalfampridine generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | Jul 11, 2018 |
2. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | Jan 23, 2017 |
3. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | Jul 30, 2018 |
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | Jan 23, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
5. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2018 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
6. MICRO LABS
Micro Labs Ltd has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | Mar 11, 2019 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
7. RISING
Rising Pharma Holding Inc has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 6, 2020 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
8. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Dalfampridine. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | May 21, 2019 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||